Report Detail

Pharma & Healthcare Global (United States, European Union and China) Female Contraceptive Market Research Report 2019-2025

  • RnM3604009
  • |
  • 19 July, 2019
  • |
  • Global
  • |
  • 110 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Female contraceptives, also known as female birth control are methods of preventing pregnancy that primarily involve the female physiology.
Female contraceptive devices account for major shares of the contraceptive pills market throughout the forecast period. The increasing adoption of female contraceptive devices will drive the growth of this product segment in the female contraceptive market.
The Americas will be the major revenue contributor to the contraceptive pills market throughout the forecast period. In this region, US will be the major contributor owing to the increased demand and adoption of female contraceptive devices.
In 2019, the market size of Female Contraceptive is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Female Contraceptive.

This report studies the global market size of Female Contraceptive, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Female Contraceptive sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Merck
Pfizer
Allergan
Bayer
Okamoto Industries
Reckitt Benckiser
Lupin Pharmaceuticals
Foundation Consumer Healthcare
Teva Pharmaceuticals
Ansell
Ferring Pharmaceuticals
Fuji Latex
Janssen Pharmaceuticals

Market Segment by Product Type
Female Contraceptive Devices
Female Contraceptive Drugs

Market Segment by Application
Online Stores
Retail Outlets

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Female Contraceptive status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Female Contraceptive manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Female Contraceptive are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025


Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Female Contraceptive Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Female Contraceptive Devices
      • 1.3.3 Female Contraceptive Drugs
    • 1.4 Market Segment by Application
      • 1.4.1 Global Female Contraceptive Market Share by Application (2019-2025)
      • 1.4.2 Online Stores
      • 1.4.3 Retail Outlets
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Female Contraceptive Market Size
      • 2.1.1 Global Female Contraceptive Revenue 2014-2025
      • 2.1.2 Global Female Contraceptive Sales 2014-2025
    • 2.2 Female Contraceptive Growth Rate by Regions
      • 2.2.1 Global Female Contraceptive Sales by Regions 2014-2019
      • 2.2.2 Global Female Contraceptive Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Female Contraceptive Sales by Manufacturers
      • 3.1.1 Female Contraceptive Sales by Manufacturers 2014-2019
      • 3.1.2 Female Contraceptive Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Female Contraceptive Revenue by Manufacturers (2014-2019)
      • 3.2.2 Female Contraceptive Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Female Contraceptive Market Concentration Ratio (CR5 and HHI)
    • 3.3 Female Contraceptive Price by Manufacturers
    • 3.4 Key Manufacturers Female Contraceptive Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Female Contraceptive Market
    • 3.6 Key Manufacturers Female Contraceptive Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Female Contraceptive Devices Sales and Revenue (2014-2019)
      • 4.1.2 Female Contraceptive Drugs Sales and Revenue (2014-2019)
    • 4.2 Global Female Contraceptive Sales Market Share by Type
    • 4.3 Global Female Contraceptive Revenue Market Share by Type
    • 4.4 Female Contraceptive Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Female Contraceptive Sales by Application

    6 United States

    • 6.1 United States Female Contraceptive Breakdown Data by Company
    • 6.2 United States Female Contraceptive Breakdown Data by Type
    • 6.3 United States Female Contraceptive Breakdown Data by Application

    7 European Union

    • 7.1 European Union Female Contraceptive Breakdown Data by Company
    • 7.2 European Union Female Contraceptive Breakdown Data by Type
    • 7.3 European Union Female Contraceptive Breakdown Data by Application

    8 China

    • 8.1 China Female Contraceptive Breakdown Data by Company
    • 8.2 China Female Contraceptive Breakdown Data by Type
    • 8.3 China Female Contraceptive Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Female Contraceptive Breakdown Data by Company
    • 9.2 Rest of World Female Contraceptive Breakdown Data by Type
    • 9.3 Rest of World Female Contraceptive Breakdown Data by Application
    • 9.4 Rest of World Female Contraceptive Breakdown Data by Countries
      • 9.4.1 Rest of World Female Contraceptive Sales by Countries
      • 9.4.2 Rest of World Female Contraceptive Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Merck
      • 10.1.1 Merck Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Female Contraceptive
      • 10.1.4 Female Contraceptive Product Introduction
      • 10.1.5 Merck Recent Development
    • 10.2 Pfizer
      • 10.2.1 Pfizer Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Female Contraceptive
      • 10.2.4 Female Contraceptive Product Introduction
      • 10.2.5 Pfizer Recent Development
    • 10.3 Allergan
      • 10.3.1 Allergan Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Female Contraceptive
      • 10.3.4 Female Contraceptive Product Introduction
      • 10.3.5 Allergan Recent Development
    • 10.4 Bayer
      • 10.4.1 Bayer Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Female Contraceptive
      • 10.4.4 Female Contraceptive Product Introduction
      • 10.4.5 Bayer Recent Development
    • 10.5 Okamoto Industries
      • 10.5.1 Okamoto Industries Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Female Contraceptive
      • 10.5.4 Female Contraceptive Product Introduction
      • 10.5.5 Okamoto Industries Recent Development
    • 10.6 Reckitt Benckiser
      • 10.6.1 Reckitt Benckiser Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Female Contraceptive
      • 10.6.4 Female Contraceptive Product Introduction
      • 10.6.5 Reckitt Benckiser Recent Development
    • 10.7 Lupin Pharmaceuticals
      • 10.7.1 Lupin Pharmaceuticals Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Female Contraceptive
      • 10.7.4 Female Contraceptive Product Introduction
      • 10.7.5 Lupin Pharmaceuticals Recent Development
    • 10.8 Foundation Consumer Healthcare
      • 10.8.1 Foundation Consumer Healthcare Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Female Contraceptive
      • 10.8.4 Female Contraceptive Product Introduction
      • 10.8.5 Foundation Consumer Healthcare Recent Development
    • 10.9 Teva Pharmaceuticals
      • 10.9.1 Teva Pharmaceuticals Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Female Contraceptive
      • 10.9.4 Female Contraceptive Product Introduction
      • 10.9.5 Teva Pharmaceuticals Recent Development
    • 10.10 Ansell
      • 10.10.1 Ansell Company Details
      • 10.10.2 Company Description and Business Overview
      • 10.10.3 Sales, Revenue and Market Share of Female Contraceptive
      • 10.10.4 Female Contraceptive Product Introduction
      • 10.10.5 Ansell Recent Development
    • 10.11 Ferring Pharmaceuticals
    • 10.12 Fuji Latex
    • 10.13 Janssen Pharmaceuticals

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Female Contraceptive Sales Channels
      • 11.2.2 Female Contraceptive Distributors
    • 11.3 Female Contraceptive Customers

    12 Market Forecast

    • 12.1 Global Female Contraceptive Sales and Revenue Forecast 2019-2025
    • 12.2 Global Female Contraceptive Sales Forecast by Type
    • 12.3 Global Female Contraceptive Sales Forecast by Application
    • 12.4 Female Contraceptive Forecast by Regions
      • 12.4.1 Global Female Contraceptive Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Female Contraceptive Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Summary:
      Get latest Market Research Reports on Female Contraceptive. Industry analysis & Market Report on Female Contraceptive is a syndicated market report, published as Global (United States, European Union and China) Female Contraceptive Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Female Contraceptive market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,280.00
      $4,920.00
      $6,560.00
      2,535.44
      3,803.16
      5,070.88
      3,053.68
      4,580.52
      6,107.36
      500,823.20
      751,234.80
      1,001,646.40
      276,832.00
      415,248.00
      553,664.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report